logo-loader
viewAgraFlora Organics International Inc.

AgraFlora taps cannabis industry veteran to drive asset commercialization

John Fowler and his team will help spot accretive corporate opportunities in domestic and international markets

AgraFlora Organics International Inc. - AgraFlora taps cannabis industry veteran to drive asset commercialization
Fowler and Blaise Ventures have been focused on driving forward the licensing and commercialization of Propagation Services Canada, and Edibles & Infusions Corporation

AgraFlora Organics International Inc (CSE:AGRA) (OCTMKTS:AGFAF), a diversified international cannabis company, said Thursday that it had engaged seasoned cannabis industry executive John Fowler to drive asset commercialization and shareholder value creation. 

In a statement, the company said it is “pleased” to welcome Fowler, who is the founder of one of Canada’s top consumer brands 7ACRES and CEO of the Supreme Cannabis Company Inc (TSX:FIRE) from 2014 to 2019. 

Fowler is a principal of Blaise Ventures Inc, a full-service consulting firm which has been engaged to support the execution of AgraFlora’s strategic priorities to “license, operationalize and solidify” a path to profitability for the company’s key assets.

READ: AgraFlora subsidiary Farmako GmbH wins special license to sell irradiated medical cannabis

A growth-oriented and diversified cannabis company, Vancouver-based AgraFlora owns an indoor cultivation facility in London, Ontario, as well as the edibles manufacturing facility in Winnipeg. The company is also a joint venture partner in Propagation Services Canada Inc (PSC), which operates a 2.2 million-square-foot greenhouse complex in Delta, British Columbia.

AgraFlora’s wholly-owned subsidiary Farmako GmbH is scaling towards its goal of being Europe’s leading distributor of medical cannabis.

The company’s main assets include Propagation Services Canada, Edibles & Infusions Corporation, AAA Heidelberg Inc and Farmako GmbH.

Eyeing accretive corporate opportunities

Fowler and his team will help AgraFlora’s management team in identifying, evaluating and executing on “accretive corporate opportunities,” including “potential acquisitions, dispositions or new revenue channels” in domestic and international markets, said the company.

“I entered 2020 looking for strong assets in the cannabis industry where I felt that our team could contribute to building strong and sustainable businesses, with a focus on engaging with key consumer segments to drive profitability and return on investment for shareholders,” said John Fowler, Principal of Blaise Ventures.

Fowler said he spent the latter part of 2019 meeting with a wide range of cannabis companies throughout Canada, and was “particularly impressed” by AgraFlora’s market opportunity, which is further amplified by its key assets.

Customer-focused businesses

“Properly aligned, the company’s assets are well positioned in 2020 to transform from development projects into customer-focused businesses that fill unmet Canadian consumer demand in true commercial cannabis edible production, high potency low cost cannabis flower, and craft cannabis,” said Fowler.

“In addition, I saw an important International segment in the Farmako subsidiary which presents a great opportunity to organically scale one of Germany’s leading medical cannabis distributors into a leading distributor of medical cannabis for all of Europe,” he added.

To date, Fowler and Blaise Ventures have been focused on driving forward the licensing and commercialization of Propagation Services Canada, and Edibles & Infusions Corporation.

Revenue generating by end of 2020

Working directly with Health Canada, AgraFlora expects its facilities to be licensed, operationalized and revenue-generating before the end of 2020. Both Propagation Services Canada, and Edibles & Infusions will focus first on driving revenue through wholesale transactions, thus accelerating revenue ramp-up while reducing associated selling and marketing costs.

The company said it will leverage Fowler’s “extensive network of large and medium-sized Canadian licensed producers, brands and processors” to further “expedite” revenue generation within “its wholesale model.”

Given the relative lack of large-scale gummy manufacturing and the opportunity for high-potency cannabis flower, management believes that both PSC and Edibles & Infusions are “well positioned” to emerge as market disruptors when they start spinning revenue in the fourth quarter.

“When I started in the cannabis industry, I did not have the luxury of experienced partners, given how nascent this evolving space was at the time,” said Fowler. “Furthermore, we had to build our business in an environment of uncertainty with respect to how the regulations and retail landscape would develop. AgraFlora is in an enviable position as it commercializes its assets at a time where most market dynamics are known.”

Contact the author Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive

Quick facts: AgraFlora Organics International Inc.

Price: 0.05 CAD

CSE:AGRA
Market: CSE
Market Cap: $21.85 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of AgraFlora Organics International Inc. named herein, including the promotion by the Company of AgraFlora Organics International Inc. in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks show little excitement; AgraFlora jumps on UK...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, declined 0.8% to 120.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF rose 0.2% to C$9.67, while the OTCQX Cannabis index edged down 0.2% to 488.6 points. Buds today...

on 23/1/20

4 min read